BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7945434)

  • 1. Metabolic interactions of methoxsalen and coumarin in humans and mice.
    Mäenpää J; Juvonen R; Raunio H; Rautio A; Pelkonen O
    Biochem Pharmacol; 1994 Oct; 48(7):1363-9. PubMed ID: 7945434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ; Madan A; Parkinson A
    Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
    Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
    Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes.
    Mäenpää J; Sigusch H; Raunio H; Syngelmä T; Vuorela P; Vuorela H; Pelkonen O
    Biochem Pharmacol; 1993 Mar; 45(5):1035-42. PubMed ID: 8461033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive inhibition of coumarin 7-hydroxylation by pilocarpine and its interaction with mouse CYP 2A5 and human CYP 2A6.
    Kinonen T; Pasanen M; Gynther J; Poso A; Järvinen T; Alhava E; Juvonen RO
    Br J Pharmacol; 1995 Nov; 116(6):2625-30. PubMed ID: 8590980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes.
    Li Y; Li NY; Sellers EM
    Eur J Drug Metab Pharmacokinet; 1997; 22(4):295-304. PubMed ID: 9512924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
    Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
    Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation.
    Pearce R; Greenway D; Parkinson A
    Arch Biochem Biophys; 1992 Oct; 298(1):211-25. PubMed ID: 1381906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P4502A-mediated coumarin 7-hydroxylation and testosterone hydroxylation in mouse and rat lung.
    Honkakoski P; Mäenpää J; Leikola J; Pasanen M; Juvonen R; Lang MA; Pelkonen O; Raunio H
    Pharmacol Toxicol; 1993 Feb; 72(2):107-12. PubMed ID: 7682690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.
    Zhang W; Kilicarslan T; Tyndale RF; Sellers EM
    Drug Metab Dispos; 2001 Jun; 29(6):897-902. PubMed ID: 11353760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High variability of nitrosamine metabolism among individuals: role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans.
    Camus AM; Geneste O; Honkakoski P; Béréziat JC; Henderson CJ; Wolf CR; Bartsch H; Lang MA
    Mol Carcinog; 1993; 7(4):268-75. PubMed ID: 8352885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver.
    Sai Y; Yang TJ; Krausz KW; Gonzalez FJ; Gelboin HV
    Pharmacogenetics; 1999 Apr; 9(2):229-37. PubMed ID: 10376770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for metabolic activation of N'-nitrosonornicotine and N-nitrosobenzylmethylamine by a rat nasal coumarin hydroxylase.
    Patten CJ; Peterson LA; Murphy SE
    Drug Metab Dispos; 1998 Feb; 26(2):177-80. PubMed ID: 9456305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.
    Kharasch ED; Hankins DC; Taraday JK
    Drug Metab Dispos; 2000 Jan; 28(1):28-33. PubMed ID: 10611136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.
    Taavitsainen P; Juvonen R; Pelkonen O
    Drug Metab Dispos; 2001 Mar; 29(3):217-22. PubMed ID: 11181487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 2A of nasal epithelium: regulation and role in carcinogen metabolism.
    Béréziat JC; Raffalli F; Schmezer P; Frei E; Geneste O; Lang MA
    Mol Carcinog; 1995 Oct; 14(2):130-9. PubMed ID: 7576100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas.
    Miyazaki M; Yamazaki H; Takeuchi H; Saoo K; Yokohira M; Masumura K; Nohmi T; Funae Y; Imaida K; Kamataki T
    Carcinogenesis; 2005 Nov; 26(11):1947-55. PubMed ID: 15958517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen.
    Yano JK; Hsu MH; Griffin KJ; Stout CD; Johnson EF
    Nat Struct Mol Biol; 2005 Sep; 12(9):822-3. PubMed ID: 16086027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2a6: role in metabolic activation of nasal toxicants.
    Liu C; Zhuo X; Gonzalez FJ; Ding X
    Mol Pharmacol; 1996 Oct; 50(4):781-8. PubMed ID: 8863822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human and mouse liver coumarin 7-hydroxylases do not metabolize warfarin in vitro.
    Honkakoski P; Arvela P; Juvonen R; Lang MA; Kairaluoma M; Pelkonen O
    Br J Clin Pharmacol; 1992 Mar; 33(3):313-7. PubMed ID: 1576054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.